| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydromyricetin | Acute Liver Injury | 1 | PM | 33681574 | 📋 | UPLC-Q-TOF/MS-Based Metabolomics Approach to Reveal the Hepatotoxicity of Emodin and Detoxification of Dihydromyricetin |
| Dihydromyricetin | Acute Pancreatitis | 1 | PM | 30055802 | 📋 | Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response |
| Dihydromyricetin | Biliary Tract Cancer | 1 | PM | 34539879 | 📋 | Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma |
| Dihydromyricetin | Biliary Tract Cancer | 2 | PM | 32913463 | 📋 | Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis via regulating miR-21 in Human Cholangiocarcinoma Cells |
| Dihydromyricetin | Colitis | 2 | PM | 38041777 | 📋 | Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway |
| Dihydromyricetin | Colitis | 1 | PM | 34273490 | 📋 | Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism |
| Dihydromyricetin | Colon Cancer | 1 | PM | 29250183 | 📋 | Ampelopsin-induced reactive oxygen species enhance the apoptosis of colon cancer cells by activating endoplasmic reticulum stress-mediated AMPK/MAPK/XAF1 signaling |
| Dihydromyricetin | Colorectal Cancer | 1 | PM | 33461143 | 📋 | Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell |
| Dihydromyricetin | Colorectal Cancer | 2 | PM | 30907395 | 📋 | Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models |
| Dihydromyricetin | Esophageal Cancer | 1 | PM | 35448920 | 📋 | [Dihydromyricetin mediates epithelial mesenchymal transformation and regulates the proliferation and apoptosis of esophageal squamous cell carcinoma cells] |
| Dihydromyricetin | Gastric Cancer | 3 | PM | 33509758 | 📋 | [Dihydromyricetin inhibits proliferation and migration of gastric cancer cells through regulating Akt/STAT3 signaling pathways and HMGB1 expression] |
| Dihydromyricetin | Gastric Cancer | 2 | PM | 32458632 | 📋 | Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells |
| Dihydromyricetin | Gastric Cancer | 1 | PM | 31894675 | 📋 | [Effects of dihydromyricetin on the migration and invasion of human gastric cancer MKN45 cells and its mechanism] |
| Dihydromyricetin | Gastrointestinal Disorders | 1 | PM | 36613665 | 📋 | Dihydromyricetin Attenuates High-Intensity Exercise-Induced Intestinal Barrier Dysfunction Associated with the Modulation of the Phenotype of Intestinal Intraepithelial Lymphocytes |
| Dihydromyricetin | Hepatic Cirrhosis | 1 | PM | 38230771 | 📋 | Study on the molecular mechanism of dihydromyricetin in alleviating liver cirrhosis based on network pharmacology |
| Dihydromyricetin | Hepatic Encephalopathy | 1 | PM | 33982639 | 📋 | Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice |
| Dihydromyricetin | Hepatic Failure | 1 | PM | 33982639 | 📋 | Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice |
| Dihydromyricetin | Hepatic Fibrosis | 3 | PM | 34867416 | 📋 | Dihydromyricetin Reverses Thioacetamide-Induced Liver Fibrosis Through Inhibiting NF-κB-Mediated Inflammation and TGF-β1-Regulated of PI3K/Akt Signaling Pathway |
| Dihydromyricetin | Hepatic Fibrosis | 2 | PM | 34147124 | 📋 | Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect |
| Dihydromyricetin | Hepatic Fibrosis | 1 | PM | 31677501 | 📋 | Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway |
| Dihydromyricetin | Hepatitis B | 1 | PM | 36474061 | 📋 | Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells |
| Dihydromyricetin | Inflammatory Bowel Disease | 1 | PM | 38041777 | 📋 | Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway |
| Dihydromyricetin | Intestinal Permeability | 1 | PM | 36678226 | 📋 | Dihydromyricetin Protects Intestinal Barrier Integrity by Promoting IL-22 Expression in ILC3s through the AMPK/SIRT3/STAT3 Signaling Pathway |
| Dihydromyricetin | Liver Cancer | 7 | PM | 37462387 | 📋 | Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation |
| Dihydromyricetin | Liver Cancer | 6 | PM | 37256172 | 📋 | Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway |
| Dihydromyricetin | Liver Cancer | 5 | PM | 34229692 | 📋 | Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells |
| Dihydromyricetin | Liver Cancer | 4 | PM | 28974890 | 📋 | Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells |
| Dihydromyricetin | Liver Cancer | 3 | PM | 28928812 | 📋 | Molecular mechanisms of ampelopsin from Ampelopsis megalophylla induces apoptosis in HeLa cells |
| Dihydromyricetin | Liver Cancer | 2 | PM | 26476886 | 📋 | Ampelopsin induces apoptosis in HepG2 human hepatoma cell line through extrinsic and intrinsic pathways: Involvement of P38 and ERK |
| Dihydromyricetin | Liver Cancer | 1 | PM | 16617784 | 📋 | [Inhibitory effects of ampelopsin on angiogenesis] |
| Dihydromyricetin | Liver Disease | 2 | PM | 35247719 | 📋 | Recent update on application of dihydromyricetin in metabolic related diseases |
| Dihydromyricetin | Liver Disease | 1 | PM | 34339914 | 📋 | Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease |
| Dihydromyricetin | MAFLD | 9 | PM | 38532480 | 📋 | Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway |
| Dihydromyricetin | MAFLD | 8 | PM | 37567321 | 📋 | A network pharmacology-based approach to explore the effect of dihydromyricetin on non-alcoholic fatty liver rats via regulating PPARG and CASP3 |
| Dihydromyricetin | MAFLD | 7 | PM | 36265611 | 📋 | Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease |
| Dihydromyricetin | MAFLD | 5 | PM | 35527487 | 📋 | [Dihydromyricetin reduces lipid accumulation in LO2 cells via AMPK/mTOR-mediated lipophagy pathway and inhibits HepG2 cell proliferation in vitro] |
| Dihydromyricetin | MAFLD | 6 | PM | 35163881 | 📋 | The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models |
| Dihydromyricetin | MAFLD | 4 | PM | 32666969 | 📋 | Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD |
| Dihydromyricetin | MAFLD | 3 | PM | 30592279 | 📋 | Protective effect of dihydromyricetin revents fatty liver through nuclear factor‑κB/p53/B‑cell lymphoma 2‑associated X protein signaling pathways in a rat model |
| Dihydromyricetin | MAFLD | 2 | PM | 29310441 | 📋 | Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling |
| Dihydromyricetin | MAFLD | 1 | PM | 26032587 | 📋 | Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial |
| Dihydromyricetin | Nasopharyngeal Cancer | 3 | PM | 35112788 | 📋 | Dihydromyricetin inhibits cancer cell migration and matrix metalloproteinases-2 expression in human nasopharyngeal carcinoma through extracellular signal-regulated kinase signaling pathway |
| Dihydromyricetin | Nasopharyngeal Cancer | 2 | PM | 34114393 | 📋 | Dihydromyricetin promotes apoptosis, suppresses proliferation and tumor necrosis factor-α-mediated nuclear factor kappa-B activation in nasopharyngeal carcinoma CNE-2 cell |
| Dihydromyricetin | Nasopharyngeal Cancer | 1 | PM | 33724059 | 📋 | Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling |
| Dihydromyricetin | Non-Alcoholic Steatohepatitis | 3 | PM | 37533083 | 📋 | Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora |
| Dihydromyricetin | Non-Alcoholic Steatohepatitis | 2 | PM | 34503544 | 📋 | Dihydromyricetin attenuates palmitic acid-induced oxidative stress by promoting autophagy via SIRT3-ATG4B signaling in hepatocytes |
| Dihydromyricetin | Non-Alcoholic Steatohepatitis | 1 | PM | 32217100 | 📋 | Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin |
